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Abstract
Women have less muscle than men but lose it more slowly during aging. To discover potential underlying mechanism(s) for
this we evaluated the muscle protein synthesis process in postabsorptive conditions and during feeding in twenty-nine 65–
80 year old men (n=13) and women (n=16). We discovered that the basal concentration of phosphorylated eEF2
Thr56 was
,40% less (P,0.05) and the basal rate of MPS was ,30% greater (P=0.02) in women than in men; the basal concentrations
of muscle phosphorylated Akt
Thr308, p70s6k
Thr389, eIF4E
Ser209, and eIF4E-BP1
Thr37/46 were not different between the sexes.
Feeding increased (P,0.05) Akt
Thr308 and p70s6k
Thr389 phosphorylation to the same extent in men and women but
increased (P,0.05) the phosphorylation of eIF4E
Ser209 and eIF4E-BP1
Thr37/46 in men only. Accordingly, feeding increased
MPS in men (P,0.01) but not in women. The postabsorptive muscle mRNA concentrations for myoD and myostatin were
not different between sexes; feeding doubled myoD mRNA (P,0.05) and halved that of myostatin (P,0.05) in both sexes.
Thus, there is sexual dimorphism in MPS and its control in older adults; a greater basal rate of MPS, operating over most of
the day may partially explain the slower loss of muscle in older women.
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Introduction
Adequate maintenance of muscle mass throughout life is
important to preserve locomotor functions and diminish the risk
of falling. Furthermore, muscle is the predominant site of body
glucose uptake [1–3] and contributes ,25% to basal energy
expenditure, and even more during physical activity [4]. Muscle,
therefore, not only serves mechanical functions but also contrib-
utes to metabolic and energy homeostasis.
It is common knowledge that healthy adult women have less
lean body mass (mostly muscle) and more fat than men [5,6].
However, the age-associated decrease in lean body mass and
muscle mass is slower in women than in men [5,7–9].
Unfortunately, little is known about the mechanisms that lead to
sexual dimorphism in body composition. It is thought that most of
it is due to differences in the sex-hormone milieu in men and
women. It has been repeatedly demonstrated in vitro [10,11], in vivo
in animal models [10,12–14], and in human subjects [15,16] that
testosterone stimulates skeletal muscle protein synthesis (MPS) and
increases muscle mass. There is also evidence that ovarian
hormones inhibit MPS [17] and muscle growth [18,19] in rats.
Nevertheless, several investigators who have measured the rates of
MPS in men and women have found no differences [20–22].
The fact that no sex differences in MPS have been reported in
the literature might be because these studies were conducted in
young and middle-age adults with a constant muscle mass during
postabsorptive conditions, when sex differences may be small or
non-existent. We reasoned that sex differences in muscle protein
turnover would become apparent at life stages when muscle mass
is changing (e.g., during growth in adolescence or wasting during
aging) and/or during acute anabolic or catabolic challenges (e.g.,
feeding or injury). Accordingly, we hypothesized that such
differences might be revealed by a comparison of rates of MPS
in older men and women during basal, postabsorptive conditions
and feeding. We, therefore, measured the fractional rate of MPS
during basal, postabsorptive conditions and during feeding by
using stable-isotope labeled amino acid tracer techniques in 65–
80 year old men and women; we also measured the concentrations
of total muscle RNA and protein to gain insight into the protein
synthetic capacity and translational efficiency of the muscle
[23,24]. Furthermore, we measured the activation (as phosphor-
ylation) of elements of intracellular signaling pathways involved in
the regulation of MPS (Akt; ribosomal protein S6 protein kinase
[p70s6k]; eukaryotic initiation factor 4E [eIF-4E]; eIF4E binding
protein 1 [eIF4E-BP1]; and eukaryotic elongation factor 2 [eEF2])
[25,26] and the mRNA expression of proteins involved in the
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myostatin [27,28] and the muscle growth factor myoD [29]). We
also measured plasma C-reactive protein (CRP) concentration as
an index of inflammation because the concentrations of CRP and
pro-inflammatory cytokines in blood have been found to be
negatively associated with rates of MPS [30] and may contribute
to skeletal muscle atrophy and reduced functional capacity,
especially during aging [31–33].
Methods
Subjects
We studied 13 men and 16 women, aged 65 to 80 y; men and
women were matched for age and body mass index (Table 1). All
subjects were considered to be in good health after completing a
comprehensive medical evaluation. None of the subjects engaged
in regular exercise, reported excessive alcohol intake, smoked, or
received hormone replacement therapy. Ten women and six men
were treated for hypertension, and four women and four men were
treated for hypercholesteremia; the drug regimen had been
initiated several years before subjects entered the study and had
been stable for several months before beginning the study.
Written, informed consent was obtained from all subjects before
their participation in the study, which was approved by the
Human Studies Committee and the General Clinical Research
Center (GCRC) Advisory Committee at Washington University
School of Medicine in St. Louis, MO.
Experimental protocol
Approximately two weeks before the protein metabolism study,
subjects’ total body fat-free mass (FFM) and appendicular muscle
mass [31] were measured by using dual-energy X-ray absorpti-
ometry (Delphi-W densitometer, Hologic, Waltham, MA). Mag-
netic resonance imaging (MRI) was used to quantify thigh muscle
volume; images were acquired with a 1.5-T superconducting
magnet (Siemens, Iselin, NJ) and a T1-weighted pulse sequence.
Eight 8-mm-thick axial images, starting 10 cm proximal to the
distal edge of the femur, with a 7-mm intersection gap, were
acquired and muscle volume in each of the images was determined
with the NIH Image Analysis Software (Analyze Direct software
(version 7.0; Mayo Clinic, Rochester, MN), which utilizes pixel
brightness to distinguish muscle from other tissues. Thigh muscle
volume in the region of interest was calculated as the sum of the
individual muscle volumes and the sum of the muscle volumes in
the intersection gap, which were assumed to be the same as in the
preceding image.
Three days before the protein metabolism study, subjects were
instructed to adhere to their usual diet and to refrain from vigorous
exercise until completion of the study. The evening before the
study, subjects were admitted to the GCRC. At 2000 h, they
consumed a standard meal which provided 50.2 kJ per kg body
weight; 15% of the meal energy was provided as protein, 55% as
carbohydrates and 30% as fat. Subjects then rested in bed and
fasted (except for water) until completion of the study the next day.
At ,0600 h on the following morning, a cannula was inserted into
an antecubital vein for the infusion of a stable isotope labeled
leucine tracer; another cannula was inserted into a vein of the
contralateral hand for blood sampling. At ,0800 h, a blood
sample and a muscle biopsy from the quadriceps femoris were
obtained to determine the background leucine enrichment in
plasma, the concentrations of testosterone, progesterone, 17ß-
estradiol, sex hormone binding globulin (SHBG), and CRP in
plasma, the background leucine enrichment in muscle tissue fluid
and muscle protein, and the concentration of total RNA and
protein in muscle. Muscle tissue (,50–100 mg) was obtained
under local anesthesia (lidocaine, 2%) by using Tilley-Henkel
forceps [34]. Immediately afterwards, a primed, constant infusion
of [5,5,5-
2H3] L-leucine (98 Atoms % purchased from Cambridge
Isotope Laboratories Inc, Andover, MA; priming dose:
4.8 mmol kg body wt
21, infusion rate: 0.08 mmol kg body
wt
21?min
21) was started and maintained until completion of the
study ,6 h later. At 210 min after the start of the leucine tracer
infusion, a second muscle biopsy was obtained to determine the
basal rate of MPS (as incorporation of [5,5,5-
2H3]leucine into
muscle protein; see Calculations) and the basal concentrations of
phosphorylated elements of intramuscular signal transduction
proteins (Akt; p70s6k; eIF-4E; eIF4E-BP1; and eEF2) involved in
the regulation of MPS. Immediately after the second biopsy, a
liquid meal (EnsureH, Abbott Laboratories, Abbott Park, IL, USA,
containing 15% of energy as protein, 55% as carbohydrate and
30% as fat) was given intermittently in small boluses every
10 minutes for 150 min so that every subject received a priming
dose of 23 mg protein?kg FFM
21 and 70 mg protein?kg
FFM
21?h
21 during the 2.5 h feeding period. At the onset of
feeding, the infusion rate of labeled leucine was increased to
0.12 mmol kg body wt
21?min
21 to adjust for the increased plasma
leucine availability. A third muscle biopsy was obtained at
360 min (i.e., 150 min after the first food aliquot) to determine
both MPS and the intracellular signaling responses to feeding. The
second and third biopsies were obtained from the leg contralateral
to that biopsied initially through the same incision, but with the
forceps directed in proximal and distal direction so that the two
biopsies were collected ,5–10 cm apart. Blood samples were
obtained every 30 min during the entire study period to determine
plasma leucine enrichment and concentration, and concentrations
of glucose, and insulin. The tracer infusions were stopped and
cannulae were removed after the last (third) biopsy and the final
blood draw were completed.
Sample collection and storage
Approximately 4 ml of blood was collected on each occasion.
One milliliter was collected in pre-chilled tubes containing
heparin, plasma separated immediately by centrifugation and
glucose concentration measured immediately. The remaining
blood (,3 ml) was collected in pre-chilled tubes containing
EDTA, plasma was separated by centrifugation within 30 min of
collection and then stored at 280uC until final analysis. Muscle
samples were rinsed in ice-cold saline immediately after collection,
Table 1. Subject characteristics
Men Women P-value
Age (years) 71626 9 61 0.16
Body mass index (kg?m
22)3 6 613 8 62 0.34
Body mass (kg)
a 108639 8 64 0.09
Fat free mass (kg)
a 67625 1 62 ,0.001
Fat free mass (% body weight) 62615 2 61 ,0.001
Appendicular muscle mass (kg)
a 29612 2 61 ,0.001
Appendicular muscle mass (% FFM) 43614 3 61 0.40
Thigh muscle volume (cm
3)
b 24776113 1963693 0.002
Values are means6SEM.
aMeasured by DEXA as described in the Experimental protocol section.
bMeasured by MRI as described in the Experimental protocol section.
doi:10.1371/journal.pone.0001875.t001
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nitrogen and stored at 280uC until final analysis.
Sample processing and analyses
Plasma glucose concentration was determined on an automated
glucose analyzer (Yellow Spring Instruments, Yellow Springs,
OH). Plasma insulin concentration was determined by radioim-
munoassay (Linco Research, St. Louis, MO). ELISA was used to
determine plasma concentrations of testosterone, progesterone,
17ß-estradiol, SHBG (all Immuno-Biological Laboratories, IBL-
America, Minneapolis, MN), and CRP (ALPCO Diagnostics,
Salem, NH).
To determine plasma leucine concentration and labeling of
plasma leucine and a-ketoisocaproate (KIC), a known amount of
norleucine was added to the plasma, proteins were precipitated,
and the supernatant, containing free amino acids and their keto-
analogues, was collected to prepare the t-butyldimethylsilyl (t-
BDMS) and trimethylsilyl derivative of leucine and KIC,
respectively, to determine their tracer-to-tracee ratios (TTR) by
gas-chromatography/mass-spectrometry (GC-MS; MSD 5973
System, Hewlett-Packard) [35].
To determine leucine labeling of muscle proteins and tissue
fluid, samples (,20 mg) were homogenized in 1 ml trichloroacetic
acid solution (3% w/v), proteins precipitated by centrifugation,
and the supernatant, containing free amino acids, collected. The
pellet containing muscle proteins was washed and then hydrolyzed
in 6 N HCl at 110 uC for 24 h. Amino acids in the protein
hydrolysate and supernatant samples were purified on cation-
exchange columns (Dowex 50W-X8-200, Bio-Rad Laboratories,
Richmond, CA), and the t-BDMS derivative of leucine prepared
to determine its TTR by GC-MS (MSD 5973 System, Hewlett-
Packard) analysis [35]. The extent of leucine labeling in plasma,
muscle tissue fluid, and muscle protein were calculated based on
the simultaneously measured TTR of standards of known isotope
labeling.
Western analysis was used to measure the phosphorylation of
Akt, p70s6k, eIF-4E, eIF4E-BP1, and eEF2. Briefly, frozen muscle
tissue (,20 mg) was rapidly homogenized with scissors in ice-cold
buffer (50 mM Tris-HCL pH 7.5, 1 mM EDTA, 1 mM EGTA,
10 mM glycerophosphate, 50 mM NaF, 0.1% Triton-X, 0.1% 2-
mercaptoethanol, 1 complete protease inhibitor tablet [Roche
Diagnostics Ltd, Burgess Hill, UK]) at 10 ml?mg
21 tissue. Proteins
were extracted by shaking for 15 min at 4uC and samples were
then centrifuged at 130006g for 10 min at 4uC and the
supernatant, containing the proteins was collected. The protein
concentration in the supernatant was determined by the Bradford
method with a commercial reagent (B6916, Sigma-Aldrich, St.
Louis, MO) and adjusted to 3 mg ml
21 in 36Laemmli buffer.
Fifty micrograms of protein from each sample were loaded onto
12% XT-Bis Tris gels, separated by SDS PAGE, and transferred
on ice at 100 V for 45 min to methanol pre-wetted 0.2 mm PVDF
membranes. Blots were then incubated sequentially with 5% (w/v)
non-fat milk for 1 h, primary antibodies overnight at 4uC, and
then secondary antibody (1:2000 anti-rabbit; New England
Biolabs, Ipswich, MA) for 1 h. The following primary antibodies
were used at a concentration of 1:1000: Akt
Thr308, p70s6k
Thr389;
4E-BP1
Thr37/46, eEF2
Thr56, and GADPH (loading control),
purchased from New England Biolabs, and eIF4E
Ser209 purchased
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Mem-
branes were developed using Immunstar (Bio-Rad Laboratories,
Richmond, CA) and the protein bands were visualized and
quantified by densitometry on a Chemidoc XRS (Bio-Rad
Laboratories, Inc. Hercules, CA) ensuring no pixel saturation.
Data were expressed in relation to GADPH.
The expression of genes involved in the regulation of muscle
mass was evaluated by real-time, reverse transcription polymerase
chain reaction (RT-PCR). Frozen tissue samples (5–10 mg) were
homogenized in TRIZOLH using a Polytron for 15 s on ice. Total
RNA was extracted according to the instructions provided by the
manufacturer (Sigma-Aldrich, St. Louis, MO) and quantified by
spectrophotometry at 260 nm. An aliquot (0.5 mg) was loaded
onto a 1% agarose gel to check RNA quality and loading by
visualization of 28s and 18s rRNA. Reverse transcription was
performed using the iScript synthesis kit (Bio-Rad Laboratories,
Richmond, CA) with 1 mg of total RNA in a reaction volume of
20 ml( 4ml iScript reaction mix, 1 ml iScript reverse transcriptase,
1 ml RNA template, 14 ml RNase-free water). The final RT
products were adjusted to 100 ml each using RNase free water.
The following primers were used for myostatin and myoD (all 59 to
39). Myostatin forward: CTA CAA CGG AAA CAA TCA TTA
CCA, reverse: GTT TCA GAG ATC GGA TTC CAG TAT;
MyoD forward: CCG CCT GAG CAA AGT AAA TG, reverse:
GCC CTC GAT ATA GCG GAT G. Sybr GreenH PCR analyses
were carried out on the iQ5 Real-Time PCR Detection System
(Bio-Rad Laboratories, Richmond, CA) using the following cycle
conditions: 3 min at 95uC, followed by 40 cycles of 1 min at 60uC,
and 15 s at 95uC. For each gene, real time RT-PCR was
conducted in duplicate in 25 ml reaction volumes containing
12.5 ml qPCR SuperMix (Bio-Rad Laboratories, Richmond, CA),
0.75 ml of each primer (10 pmol ml
21), 9 ml RNAse-free water and
2 ml of 1:5 diluted cDNA. PCR products were checked for
amplicon specificity by both melting curve and agarose gel
electrophoresis. Results were analyzed using the 2-DDCt method
with 28s as internal control [36]. Due to lack of sufficient muscle
tissue, these analyses were carried out in only 7 of the 13 men and
7 of the 16 women.
Todetermine the totalRNAto protein ratioinmuscle,an indexof
the capacity for protein synthesis, an aliquot of the total RNA
preparation prepared for RT-PCR was sequentially extracted
(RNA.DNA.protein) according to the manufacturers (Sigma-
Aldrich, St. Louis, MO) protocol. Total RNA was quantified after
complete removal of the upper phase following phase separation;
protein concentration was quantified after removal of the DNA
interphase and precipitation of proteins with acetone from the
bottom layer, which were then washed and resuspended in 1% SDS.
Total RNA was quantified (in mg per g wt weight) spectrophotomet-
rically at 260 nm and protein was quantified (in mg per g wt weight)
at 595 nm using Bradford reagents at a 1:10 dilution to reduce SDS
interference. Due to lack of sufficient muscle tissue, these analyses
were carried out in only 9 of the 13 men and 7 of the 16 women.
Calculations
Leucine rate of appearance (Ra) in plasma was calculated by
dividing the rate of [5,5,5–
2H3]leucine infusion by the steady state
plasma KIC TTR during basal, postabsorptive conditions and
feeding. Leucine Ra during basal conditions is an index of the rate
of whole-body proteolysis; during feeding, leucine Ra represents
the sum of the rate of leucine release into plasma from proteolysis
plus the rate of transfer of absorbed leucine from the meal into the
systemic circulation.
The fractional synthesis rate (FSR) of mixed muscle protein was
calculated from the rate of incorporation of [5,5,5-
2H3]leucine
into muscle protein, using a standard precursor-product model as
follows: FSR=DEp/Eic61/t6100; where DEp is the change
between two consecutive biopsies in extent of labeling (TTR) of
protein-bound leucine. Eic is the mean labeling over time of the
precursor for protein synthesis and t is the time between biopsies.
The free leucine labeling in muscle tissue fluid was chosen to
Muscle Anabolism
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RNA) [37]. Values for FSR are expressed as %?h
21. The absolute
rate of muscle protein synthesis (g protein per hour) was calculated
by multiplying the FSR by the total appendicular muscle protein
mass, which was assumed to be 20% of total appendicular muscle
mass. We have recently found that differences in the rates of
muscle protein synthesis in different muscles are negligible[38];
thus, it is reasonable to extrapolate our data obtained in the vastus
lateralis to all skeletal muscles in the body.
The translation efficiency (mg protein produced per mg RNA
per hour) was calculated by dividing the product of the muscle
protein FSR (in %?h
21) and the muscle protein concentration (in
mg per g wet tissue) by the muscle total RNA concentration (in mg
per g wet tissue) [23,24].
Statistical analysis
All data sets were tested for normality. Differences between men
and women in subject characteristics and single time-point
measurements (e.g., plasma sex hormone and CRP concentrations)
were evaluated by using Student’s t-testfor normally distributed data
and the Mann-Whitney U test for data which were not normally
distributed (i.e., plasma SHBG, testosterone, progesterone, 17ß-
estradiol and CRP concentrations). Analysis of variance (ANOVA)
wasusedtoevaluatepossibledifferencesbetweenmenandwomenin
plasma glucose, insulin, and leucine concentrations, muscle protein
FSR, muscle intracellular signaling elements, and muscle mRNA
expression during postabsorptive and fed conditions. If necessary,
data were log transformed to achieve normally distributed data sets
before analysis. A P value of #0.05 was considered statistically
significant. Data in the text are presented as mean6SEM or median
with25
thand 75
thpercentilesin bracketsforskeweddatasets;datain
tables and figures are presented as indicated in the legends.
Results
Subjects’ age and body-composition
Men and women were matched for age and BMI (Table 1).
Total body FFM, total muscle mass and leg muscle volume were
,25% less in women than in men; however, the relative
contribution of muscle mass to total body FFM was not different
in men and women (Table 1).
Plasma sex hormone and CRP concentrations
Plasma SHBG concentration was not different between men
and women (Table 2). Plasma testosterone concentration was 10
times greater (P,0.001) in men than in women whereas plasma
progesterone and 17ß-estradiol concentrations were not different
between the sexes (Table 2). Plasma CRP concentration was not
different between men and women (Table 2).
Plasma glucose, insulin, and leucine concentrations
Basal plasma glucose and insulin concentrations were not
different between men and women (Table 3). Feeding increased
plasma glucose concentration by ,25% (P,0.001) and plasma
insulin concentration by ,200% (P,0.001) with no differences
between the sexes (Table 3). Basal plasma leucine concentration
was ,15% less in women than in men (Table 3), and feeding
increased plasma leucine concentration by ,15% (P,0.001) in
both sexes (Table 3).
Whole-body leucine Ra
Rates of leucine Ra during basal, postabsorptive conditions (an
index of whole-body protein breakdown) and total leucine Ra
during feeding were not different in men (2.2460.08 and
2.5660.08 mmol kg
21 FFM?min
21, respectively) and women
(2.2060.09 and 2.6260.09 mmol kg
21 FFM?min
21, respectively).
Muscle protein synthesis
The capacity for MPS (i.e., total RNA-to-protein ratio in
muscle) tended to be greater (by ,20%; P=0.18) in women than
in men (5.860.6 vs. 4.760.5 mg RNA?mg protein
21, respectively).
Mixed muscle protein FSR during basal, postabsorptive
conditions was ,30% greater (P=0.02) in women than in men
(Figure 1). Feeding had no effect on the FSR in women but
increased (P,0.01) it in men to values similar to those in women
(Figure 1). The absolute rate of muscle protein synthesis, adjusted
for differences in total muscle mass between the sexes, was 116
[104, 143] mg of muscle protein per hour per kg of appendicular
skeletal muscle mass in women and 90 [78, 115] mg of muscle
protein per hour per kg of appendicular skeletal muscle mass in
men (P=0.02); it increased by 35 [13, 79] mg per hour per kg of
appendicular skeletal muscle mass in response to the meal in men
(P,0.01), but did not change significantly from basal values (by 11
[210, 41] mg of muscle protein per hour per kg of appendicular
skeletal muscle mass) in women.
The rate of MPS in relation to muscle RNA concentration, a
measure of the translational efficiency in muscle, was not different
between men and women during basal, postabsorptive conditions
(0.01260.003 vs. 0.01360.002 mg protein?mg RNA
21?h
21) and
increased with feeding in men (to 0.01960.006 mg protein?mg
RNA
21?h
21; P=0.058 vs basal) but not in women (to
0.01560.001 mg protein?mg RNA
21?h
21).
Phosphorylation of signaling transduction proteins in
muscle
In the postabsorptive state, the extent of phosphorylation of
Akt
Thr308, p70s6k
Thr389, eIF4E
Ser209 and eIF4E-BP1
Thr37/46 in
muscle was not different in men and women (Figure 2). The
Table 2. Plasma sex hormone and CRP concentrations.
Men Women
SHBG (nmol l
21) 23.1 (20.1, 26.0) 25.9 (19.2, 44.8)
Testosterone (nmol l
21) 12.2 (8.8, 18.1) 1.1 (0.9, 1.7)*
Progesterone (ng ml
21) 0.12 (0.05, 0.31) 0.04 (0.02, 0.12)
17ß-Estradiol (pg ml
21) 11.3 (10.8, 30.9) 10.9 (10.0, 11.9)
CRP (mg l
21) 3.08 (2.43, 4.23) 2.80 (0.98, 3.60)
Values are median with quartiles in parentheses.
*Value significantly different from corresponding value in men (P,0.001).
doi:10.1371/journal.pone.0001875.t002
Table 3. Plasma glucose, insulin, and leucine concentrations.
Men Women
Fasted Fed Fasted Fed
Glucose (mmol l
21)5 . 2 60.1 6.560.2
{ 5.460.2 6.960.1
{
Insulin (mUm l
21) 15.562.2 47.867.3
{ 14.463.1 41.565.6
{
Leucine (mmol l
21)1 3 3 64 14464
{ 11166* 12666*
{
Values are mean6SEM.
*Value significantly different from corresponding value in men (P=0.011);
{value significantly different from corresponding value during basal,
postabsorptive (fasted) conditions (P,0.001).
doi:10.1371/journal.pone.0001875.t003
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Thr308,
p70s6k
Thr389 (both P,0.01) were also not different in the two sexes
(Figure 2). In contrast, feeding increased (P,0.01) the phosphor-
ylation of eIF4E
Ser209 and eIF4E-BP1
Thr37/46 in men but had no
effect on their phosphorylation in women (Figure 2). Phosphor-
ylated eEF2
Thr56 in muscle was ,40% less (P,0.05) in women
than in men both during postabsorptive conditions and feeding
(Figure 2); there was a tendency for a decrease in the
phosphorylation of eEF2
Thr56 in both sexes with feeding
(Figure 2) but this difference did not reach statistical significance
(P=0.103).
mRNA expression of proteins involved in the regulation
of muscle mass
The mRNA concentrations of myostatin and myoD during
postabsorptive conditions were not different in men and women
(Figure 3). Feeding decreased the concentration of myostatin
mRNA (P,0.05) and increased the concentration of myoD
mRNA (P,0.05) to the same extent in the two sexes (Figure 3).
Discussion
In this study we uncovered marked sexual dimorphism between
older men and women in a variety of aspects of muscle protein
metabolism. The differences we observed between older men and
women, namely a ,30% greater basal rate of mixed MPS in
women than in men and resistance of MPS to feeding a liquid
mixed meal (providing a total of ,10 g of protein) in women, are
consistent with a recent study in which comprehensive oligonu-
cleotide microarrays were used to discover potential differences
between men and women in the expression of genes involved in
the regulation of muscle mass [39]; in this study it was found that
women had a two-fold greater expression of two genes that encode
proteins with inhibitory properties on growth factor pathways in
muscle. On the other hand, the results from our study are in clear
contrast to the results from previous workers who searched for
potential sex differences in human muscle protein metabolism and
found none [20–22]. However, those earlier studies were
conducted in young adults (average age: 23–27 y) and we
hypothesized that sex differences in human muscle protein
turnover would only become apparent at life stages when muscle
mass was changing (e.g., during adolescent growth or wasting
during aging) and/or possibly during acute anabolic or catabolic
challenges (e.g., with feeding or injury). To our knowledge the
current work is the first to demonstrate in human beings sex
differences in the rate of MPS and provides some insight
concerning the control of MPS and the different rates of muscle
loss with aging between men and women.
The greater basal rate of mixed MPS in older women was
probably mediated by a combination of a greater capacity for
protein synthesis combined with a relatively more active
translational process at the elongation stage of protein synthesis
because first, there was the trend for a ,20% greater muscle
RNA-to-protein ratio in women than in men, indicating a greater
capacity for MPS [24] in them and secondly, muscle of older
women had a 40% smaller degree of phosphorylation of
eEF2
Thr56, a molecule regulating elongation of nascent protein
chains which is deactivated by phosphorylation [25]. We found no
differences between sexes in the extent of phosphorylation for
components of the PKB/mTOR/p70s6k signaling pathway, or
the phosphorylation of elements involved in the regulation of
translation initiation (eIF4E and eIF4e-BP1) at baseline (fasted).
Furthermore, the expression in muscle of mRNA for myostatin
and myoD, cell regulatory proteins affecting muscle size [26–29],
was not different between the sexes, which makes it unlikely that
they are involved in regulating the basal rate of MPS, although, we
cannot from our data rule out differences in the muscle myostatin
and myoD protein concentration (and thus in cell function).
Indeed, a greater myostatin protein concentration has been found
in female than male mice [40], which is consistent with the
observed sexual dimorphism in muscle mass but not with our
results of a lower basal rate of MPS in older men, assuming
extrapolation between species is valid. Plasma glucose, insulin, and
CRP concentrations were not different in men and women, so
these results also provide no explanation of baseline sex differences
in MPS.
Figure 1. Muscle protein synthesis rate in men and women.
Panels A and B show the mixed skeletal muscle protein fractional
synthesis rate (FSR) during basal, post-absorptive conditions (fasted)
and liquid mixed meal consumption (fed) in men and women (A) and
the meal-induced change in the FSR in men and women (B). Graphs
show the median (central horizontal line), 25
th and 75
th percentiles
(box), and minimum and maximum values (vertical lines). * Value
significantly different from corresponding value in men.
{ Value
significantly different from corresponding value during basal, postab-
sorptive (fasted) conditions.
doi:10.1371/journal.pone.0001875.g001
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dimorphism in muscle protein metabolism and its control is
apparently of late onset (aging, as in the present study, vs. young
and middle-age adulthood [20–22]) are not clear but are most
probably related to the changes with advancing age in the sex
hormone milieu. This may at first seem counterintuitive, because
men had a ten-fold excess of testosterone compared with women,
with a concomitant relatively small or no difference in plasma
progesterone and estradiol concentration between the sexes.
Testosterone is well known to be anabolic and increases the basal
rate of MPS in both healthy and hypogonadal young men
[15,16,41]. Oddly, however, the effect of testosterone therapy in
older men is unclear; it has been shown by the same group, in
different studies, to either increase [42] or not to affect [43] the
basal rate of MPS. This discrepancy might be a dose- or
treatment duration-related phenomenon, or depend upon the
extent of initial testosterone deficiency. More importantly,
however, we [44] and others [45] measured the basal rate of
MPS in large cohorts of healthy young (n$22) and old (n$22)
men and found that it was not affected by old age. This suggests
that the normal decline in testosterone with aging, which is small
[45], probably has little effect on the basal rate of MPS. On the
other hand, there is evidence from studies in rats that
progesterone and estrogen inhibit MPS. Specifically, it was found
that in ovariectomized rats the rate of MPS was higher than in
sham-operated, intact controls and ovariectomy with either
progesterone or estrogen replacement prevented the increase
[17]. Thus, it appears that the basal rate of MPS probably
increases after menopause due to a lack of female sex steroids,
which leads to pronounced differences in the basal rate of MPS
between men and women not apparent in younger adults.
Moreover, these and our findings (i.e., greater basal rate of MPS
in women than men despite 10-fold difference in plasma
testosterone concentration) suggest that the anti-anabolic effect
of female sex steroids on MPS may by far outweigh the anabolic
effect of testosterone.
Figure 2. Phosphorylation of anabolic signaling transduction molecules in muscle of men and women. Panels A–E show concentrations
of phosphorylated Akt
Thr308 (A), p70s6k
Thr389 (B), eIF4E-BP1
Thr37/46 (C), eIF4E
Ser209 (D), and eEF2
Thr56 (E) during basal, postabsorptive conditions
(fasted) and liquid mixed meal consumption (fed) in men and women. Values are means6SEM. * Value significantly different from corresponding
value in men;
{ Value significantly different from corresponding value during basal, postabsorptive (fasted) conditions.
doi:10.1371/journal.pone.0001875.g002
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postabsorptive rate of MPS in women was faster despite lower
basal plasma leucine concentrations in women than in men. There
is ample evidence that the rate of MPS is directly related to plasma
amino acid availability [44,46,47], particularly that of plasma
leucine [48–51]. However, this relationship has been established
when plasma amino acid/leucine concentrations were varied
several-fold, whereas the difference in plasma leucine concentra-
tion in our men and women was only ,15%, possibly too small to
exert a noticeable effect on the rate of MPS as MPS only increases
by 50% with a doubling of leucine concentration [46].
The slightly greater postabsorptive plasma leucine concentra-
tion in men, which is in excellent agreement with an earlier report
on sex differences in the plasma amino acid profile [52], probably
reflects greater net negative protein balance in men than in women
but it is difficult to assign components to this, beyond the
decreased MPS in men. We did not measure the rate of muscle
protein breakdown (MPB) (which was unwarranted without more
indicative data of possible sex differences given the already sizeable
investigational burden on our subjects). Therefore we are unable
to estimate muscle protein net balance. However, whole-body
protein breakdown (indicated by leucine Ra) was not different
between our men and women and as MPB normally accounts for
,20–40% of a healthy person’s postabsorptive whole-body
protein breakdown rate [53,54] it is unlikely that MPB was
markedly accelerated in men compared with women.
The differences in the anabolic response to feeding between the
sexes, with men showing a significant increase and women no
significant increase in MPS, was probably partially mediated by a
lack of stimulation by feeding of protein translation initiation in
female muscle, given that the feeding increased the phosphoryla-
tion of muscle eIF4E
Ser209 and eIF4E-BP1
Thr37/46 in men but not
in women. This is particularly interesting given the facts that other
indices of anabolic signaling, like the feeding-induced changes in
the phosphorylation of Akt
Thr308, p70s6k
Thr389, and eEF2
Thr56
were similar in men and women. An intriguing new finding was
the marked (and so far as we can tell previously unreported)
changes in the expression of myostatin and myoD with feeding,
which are consistent with an acute nutritional control at the level
of the nucleus of processes regulating muscle mass [55].
Nevertheless, there was no apparent sex difference in these
responses, which makes it unlikely that the feeding-induced
changes in myostatin and myoD expression contributed to the
blunted increase of MPS to feeding in women. The feeding-
induced increases in plasma glucose, insulin, and leucine
concentrations were not different in men and women, which
suggests that these also were not involved in the apparent anabolic
resistance in women. It is possible, however, that there were sex
differences in the insulin-stimulated increase in muscle nutritive
blood flow which would differentially affect amino acid delivery to
the muscle. Although in young adults, the insulin mediated
vasodilation is greater in women than in men [56], there is
evidence for a greater decline with aging in women compared with
men in endothelium dependent dilation induced pharmacologi-
cally or by hypoxia [57–59], which may abolish this difference at a
more advanced age or even result in reduced flow in women.
However all these observations were for measures of bulk blood
flow and no pertinent results exist, to our knowledge, for muscle
microvascular perfusion [60]. The impact of the sex hormone
milieu on the anabolic effect of feeding in muscle is unknown
largely due to a lack of data in the literature. To our knowledge, no
one has determined the effect of female sex steroids on the
anabolic effects of amino acids or food in muscle; however, neither
testosterone [43] nor oxandrolone [61] were found to exert an
acute additive effect to the stimulatory effect of amino acids on
MPS.
Our findings provide a potential mechanism that may help to
explain the slower rate of muscle wasting during aging in women
than in men [5,7–9]. There is no data available for diurmal
variation in human muscle MPS but we suggest that the basal,
postabsorptive rate, which was ,30% greater in our women than
in the men, most likely predominates over most of the day. Our
arguments depend upon a number of observations. First, the data
available from protein intakes in French [62] and North American
[63,64] older adults indicate that individuals between 65–80 y eat
on average approximately 9–14 g protein at breakfast, 38–64 g
protein at lunch, 19–33 g protein at dinner and 1.2–1.7 g protein
in snacks [62]. Secondly, meal feeding causes an increase of
plasma total amino acid concentrations that is proportional to the
amount of protein consumed for approximately 3–5 h, after which
the change returns to within 25% of baseline [65–67]. Thirdly, the
results of a study of the circadian variations of amino acids during
a 24-h long study of the effects of 3 meals and two snacks suggested
Figure 3. Muscle mRNA expression of proteins involved in the
regulation of muscle mass in men and women. Panels A and B
show myostatin (A) and myoD (B) gene expression during basal,
postabsorptive conditions (fasted) and liquid mixed meal consumption
(fed) in men (n=7) and women (n=7). Values are means6SEM.
{ Value
significantly different from corresponding value during basal, postab-
sorptive (fasted) conditions; P,0.05.
doi:10.1371/journal.pone.0001875.g003
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the postabsorptive morning value was approximately 7 h [68].
Fourth, there is evidence that a sustained hyperaminoacidemia
does not lead to a sustained increase in MPS, which returns to
baseline values within approximately 2–2.5 h of the initial increase
of amino acid availability [69]. Lastly, the relationship between
amino acid availability and MPS is saturable both for orally
delivered free amino acids [44] and orally delivered protein [70],
with excess essential amino acids being oxidized above delivery of
approximately 15 g of protein per meal in young trained
individuals [70] and probably even less in older adults [44]. Thus,
we suggest that MPS proceeds at a rate corresponding closely to
fed values in our study for approximately 6–8 h; for the remainder
of the day, MPS would presumably operate at or near
postabsorptive values. This then would result in a lower than
average rate of MPS over the course of the day than in women.
We recognize that a complete description of the mechanisms
involved in nutritional regulation of muscle mass in the elderly will
depend on information about the meal induced changes in muscle
protein breakdown. To date, there is no evidence that the
sensitivity of MPS in older men and women to insulin released by
feeding is different. Furthermore, in a study of 6 older men and 6
older women (68–70 y), who received two doses of insulin during
hyperinsulinaemic, isoaminoacidemic clamps, leucine whole body
Ra (an index of whole-body proteolysis) was not different between
the sexes [71]. Additional support comes from a study of 30 y old
men and women, in which it was observed that the inhibitory
effect of insulin on whole-body proteolysis (assessed during a
hyperinsulinemic, euglycemic, isoaminoacidemic clamp) was not
different between the sexes but, consonant with our results, in
women there appeared to be an anabolic resistance to the
stimulatory effect of insulin on whole-body protein synthesis [72].
In summary, we have demonstrated that there is significant
sexual dimorphism in MPS and its control in older adults; a
greater basal rate of MPS, operating over a large portion of the
diurnal cycle, may be, at least in part, responsible for the slower
loss of muscle in women than in men.
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